Skip to main content
EURK
NASDAQ Energy & Transportation

Nasdaq Grants Eureka Extension to January 31, 2027 on Public Float Deficiency

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Energy
Sentiment info
Neutral
Importance info
7
Price
$11.55
Mkt Cap
$25.07M
52W Low
$10.14
52W High
$14.28
52W Position info
14% above low
Off High info
19% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

EURK is trading near its 52-week low of $10.14 (14% above the low) on light trading volume (0.1× avg).

Summary

Nasdaq accepted Eureka's October 12 compliance plan and gave the SPAC until January 31, 2027 to regain compliance with the public float listing rule. The deficiency itself was already disclosed in September; this is the extension, not a cure.


Key Events · Corporate Governance and Compliance · EURK

  • Nasdaq Grants Public Float Extension

    On October 26, 2026, Nasdaq's Listing Qualifications Department granted Eureka an extension through January 31, 2027 to regain compliance with Listing Rule 5450(a)(4), the public float rule.

  • Compliance Plan Filed October 12

    The company submitted its plan to regain compliance on October 12, 2026, the deadline under the 45-calendar-day window that began with the August 27, 2026 notice.

  • Deficiency Still Unresolved

    The extension defers, but does not cure, the listing deficiency; compliance must be achieved by January 31, 2027 or the shares face delisting proceedings.

  • Merger Clock Runs in Parallel

    The listing cure deadline sits alongside the pending Marine Thinking business combination and a previously disclosed going-concern warning with a heavily redeemed public float.


Analysis · EURK · Energy & Transportation

Eureka now has roughly three more months to fix the listing deficiency it disclosed in September. The relief is real but narrow: the company must still satisfy Nasdaq's public float standard by January 31, 2027, and it is simultaneously trying to close a SPAC merger with Marine Thinking while carrying a going-concern warning and a heavily redeemed public float. A failed cure means delisting, which would put the merger and the remaining shareholder base at risk.

How filings like this one have moved

In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EURK was trading at $11.55 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $25.1M. The 52-week trading range was $10.14 to $14.28. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EURK - Latest Insights

EURK
Sep 14, 2026, 9:28 AM EDT
Filing Type: S-4/A
Importance Score:
8
EURK
Sep 02, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
EURK
Jul 22, 2026, 8:43 PM EDT
Filing Type: 10-Q
Importance Score:
9
EURK
Jul 10, 2026, 6:03 AM EDT
Source: Wiseek News
Importance Score:
7
EURK
Jul 06, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8